Last reviewed · How we verify

NCT06185803: SPEDAL

Predictors of Anterior Patellofemoral Pain After Anterior Cruciate Ligament Reconstruction

Active, enrolled Last updated 8 June 2025
What this trial tests

trial testing anterior cruciate ligament reconstruction in Anterior Cruciate Ligament Reconstruction in 500 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
27 July 2023
Primary endpoint
28 February 2026
30 June 2026

Quick facts

Lead sponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment500
Start date27 July 2023
Primary completion28 February 2026
Estimated completion30 June 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →

Who can join

18 and older, any sex, with Anterior Cruciate Ligament Reconstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational, ambispective, longitudinal, monocentric, open cohort study of a population of adult patients operated on for ACL reconstruction and receiving postoperative follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of anterior cruciate ligament reconstruction

Trials testing the same drug.

Other recruiting trials for Anterior Cruciate Ligament Reconstruction

Currently open trials in the same condition.

Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06185803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing